NBC News · 9h
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Fierce Healthcare · 4d
Express Scripts files suit against FTC, demands retraction of report on PBM industry
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry. | Express Scripts has filed suit against the Federal Trade Commission,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results